Skip to main content

Research Repository

Advanced Search

Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells

Kitchen, Mark O.; Yacqub-Usman, Kiren; Emes, Richard D.; Richardson, Alan; Clayton, Richard N.; Farrell, William E.

Authors

Mark O. Kitchen

Kiren Yacqub-Usman

Richard D. Emes

Richard N. Clayton

William E. Farrell



Abstract

Introduction
Transgenic mice overexpressing the high mobility group A (HMGA) genes, Hmga1 or Hmga2 develop pituitary tumours and their overexpression is also a frequent finding in human pituitary adenomas. In some cases, increased expression of HMGA2 but not that of HMGA1 is consequent to genetic perturbations. However, recent studies show that down-regulation of microRNA (miRNA), that contemporaneously target the HMGA1 and HMGA2 transcripts, are associated with their overexpression.

Results
In a cohort of primary pituitary adenoma we determine the impact of epigenetic modifications on the expression of HMGA-targeting miRNA. For these miRNAs, chromatin immunoprecipitations showed that transcript down-regulation is correlated with histone tail modifications associated with condensed silenced genes. The functional impact of epigenetic modification on miRNA expression was determined in the rodent pituitary cell line, GH3. In these cells, histone tail, miRNA-associated, modifications were similar to those apparent in human adenoma and likely account for their repression. Indeed, challenge of GH3 cells with the epidrugs, zebularine and TSA, led to enrichment of the histone modification, H3K9Ac, associated with active genes, and depletion of the modification, H3K27me3, associated with silent genes and re-expression of HMGA-targeting miRNA. Moreover, epidrugs challenges were also associated with a concomitant decrease in hmga1 transcript and protein levels and concurrent increase in bmp-4 expression.

Conclusions
These findings show that the inverse relationship between HMGA expression and targeting miRNA is reversible through epidrug interventions. In addition to showing a mechanistic link between epigenetic modifications and miRNA expression these findings underscore their potential as therapeutic targets in this and other diseases.

Journal Article Type Article
Online Publication Date Jan 4, 2015
Publication Date 2015-10
Deposit Date Jun 9, 2023
Journal Pituitary
Print ISSN 1386-341X
Electronic ISSN 1573-7403
Publisher Springer Verlag
Peer Reviewed Peer Reviewed
Volume 18
Issue 5
Pages 674-684
DOI https://doi.org/10.1007/s11102-014-0630-5
Keywords Endocrinology; Endocrinology, Diabetes and Metabolism; Pituitary; microRNA; Chromatin; Epidrugs; HMGA1